Pharmaceutical company AbbVie (NYSE:ABBV) will be reporting earnings this Wednesday before market open. Last quarter, AbbVie beat revenue expectations by 1.2%, with revenues at $15.78 billion, up 9.1% year on year. Analysts expect revenue to grow 7.6% to $16.25 billion this quarter and adjusted earnings per share to be $2.65. AbbVie has a history of exceeding Wall Street’s expectations. In the biotechnology segment, Regeneron beat revenue estimates by 2.7%. AbbVie’s share price is up 2.7% over the last month and has an average analyst price target of $243.35.

Read more at Stockstory.org does not belong to a specific media company.: AbbVie (ABBV) Q4 Earnings: What To Expect